Cameron’s Law

This bill would increase a tax credit for companies that develop drugs for rare diseases. Currently, companies can get a tax credit equal to 25% of the money they spend on testing these drugs. This bill would raise that credit to 50%. The credit was previously 50% before 2018, when it was lowered to 25%.

Your Vote